These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35778411)

  • 1. Metabolic modeling-based drug repurposing in Glioblastoma.
    Tomi-Andrino C; Pandele A; Winzer K; King J; Rahman R; Kim DH
    Sci Rep; 2022 Jul; 12(1):11189. PubMed ID: 35778411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Trials and Therapeutic Rationale for Drug Repurposing in Schizophrenia.
    Lago SG; Bahn S
    ACS Chem Neurosci; 2019 Jan; 10(1):58-78. PubMed ID: 29944339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug repurposing: a promising tool to accelerate the drug discovery process.
    Parvathaneni V; Kulkarni NS; Muth A; Gupta V
    Drug Discov Today; 2019 Oct; 24(10):2076-2085. PubMed ID: 31238113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative rare disease biomedical profile based network supporting drug repurposing or repositioning, a case study of glioblastoma.
    McGowan E; Sanjak J; Mathé EA; Zhu Q
    Orphanet J Rare Dis; 2023 Sep; 18(1):301. PubMed ID: 37749605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on Drug Repurposing: Re-written saga of the drug's fate.
    Gns HS; Gr S; Murahari M; Krishnamurthy M
    Biomed Pharmacother; 2019 Feb; 110():700-716. PubMed ID: 30553197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.
    Zhang M; Schmitt-Ulms G; Sato C; Xi Z; Zhang Y; Zhou Y; St George-Hyslop P; Rogaeva E
    PLoS One; 2016; 11(12):e0168812. PubMed ID: 28005991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards the routine use of in silico screenings for drug discovery using metabolic modelling.
    Bintener T; Pacheco MP; Sauter T
    Biochem Soc Trans; 2020 Jun; 48(3):955-969. PubMed ID: 32369553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma.
    Persico M; Abbruzzese C; Matteoni S; Matarrese P; Campana AM; Villani V; Pace A; Paggi MG
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations and challenges for sex-aware drug repurposing.
    Fisher JL; Jones EF; Flanary VL; Williams AS; Ramsey EJ; Lasseigne BN
    Biol Sex Differ; 2022 Mar; 13(1):13. PubMed ID: 35337371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling Path Importance for Effective Alzheimer's Disease Drug Repurposing.
    Xiang S; Lawrence PJ; Peng B; Chiang C; Kim D; Shen L; Ning X
    Pac Symp Biocomput; 2024; 29():306-321. PubMed ID: 38160288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic integration of biomedical knowledge prioritizes drugs for repurposing.
    Himmelstein DS; Lizee A; Hessler C; Brueggeman L; Chen SL; Hadley D; Green A; Khankhanian P; Baranzini SE
    Elife; 2017 Sep; 6():. PubMed ID: 28936969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing.
    Zador Z; King AT; Geifman N
    PLoS One; 2018; 13(3):e0194701. PubMed ID: 29558515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug repurposing for the treatment of glioblastoma multiforme.
    Abbruzzese C; Matteoni S; Signore M; Cardone L; Nath K; Glickson JD; Paggi MG
    J Exp Clin Cancer Res; 2017 Nov; 36(1):169. PubMed ID: 29179732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Data-driven drug discovery for drug repurposing].
    Saito R; Yano N; Kojima S; Miyoshi F
    Nihon Yakurigaku Zasshi; 2023; 158(1):10-14. PubMed ID: 36596476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of drug candidates and repurposing opportunities through compound-target interaction networks.
    Cichonska A; Rousu J; Aittokallio T
    Expert Opin Drug Discov; 2015 Dec; 10(12):1333-45. PubMed ID: 26429153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current state and future perspective of drug repurposing in malignant glioma.
    Siegelin MD; Schneider E; Westhoff MA; Wirtz CR; Karpel-Massler G
    Semin Cancer Biol; 2021 Jan; 68():92-104. PubMed ID: 31734137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Methods for Drug Repurposing.
    Rapicavoli RV; Alaimo S; Ferro A; Pulvirenti A
    Adv Exp Med Biol; 2022; 1361():119-141. PubMed ID: 35230686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning.
    Turanli B; Zhang C; Kim W; Benfeitas R; Uhlen M; Arga KY; Mardinoglu A
    EBioMedicine; 2019 Apr; 42():386-396. PubMed ID: 30905848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
    Wang Y; Yang Y; Chen S; Wang J
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.